Background Image
Table of Contents Table of Contents
Previous Page  28 / 40 Next Page
Information
Show Menu
Previous Page 28 / 40 Next Page
Page Background

RESEARCH ARTICLE

SA JOURNAL OF DIABETES & VASCULAR DISEASE

70

VOLUME 16 NUMBER 2 • NOVEMBER 2019

dietary intake may be a worthy approach to decrease elongation of

n-

6 FAs leading to reduced plasma C20:4

n-

6 levels and increased

plasma levels of C22:6

n-

3 and C20:5

n-

3.

58

As C18:3

n-

3 is an

essential FA, this pattern, identified in our study participants, is

probably related to food intake and therefore indicative of a higher

intake of vegetable oils, legumes, nuts and seeds.

61

Strengths and limitations

A rigorous methodological approach of sequential regression

modelling enabled us to investigate the associations between

dietary FA and plasma phospholipid FA patterns, respectively, and

measures of adiposity and the MetS. Another strength of our study

is the use of both dietary FA and plasma phospholipid FA patterns,

27

which is a preferred method to investigate the association between

diet and diseases.

27

Our work is not free of limitations. Firstly, inaccuracies

associated with collecting dietary intake data may have influenced

the dietary FA results; however, in our population, fieldworkers

collecting dietary data were intensively trained and supervised, and

both under- and over-reporters of dietary intake were excluded.

50

In addition, repeatability of the QFFQ was also demonstrated.

10

Secondly, the cross-sectional design does not account for possible

reverse causation between measures of adiposity and dietary FA

intake or plasma phospholipid FA concentration, nor can causality

be inferred. Thirdly, a possible limitation of the study is incomplete

information on FA composition in the food composition databases.

This limitation was compensated for by our study design that also

considered plasma phospholipid FAs. Fourthly, we assessed the

associations with indirect measurements of adiposity, including

BMI, WHtR and WC, as secondary markers of total and central

adiposity, whereas imaging methods would better differentiate

between lean and fat mass.

Conclusion

To our knowledge, this is the first study to investigate and

document novel data on dietary FA and plasma phospholipid FA

patterns and their association with measures of adiposity and the

MetS in a selected group of black South African adults. This study

presents evidence that although marginal association was found

with dietary FA patterns, some circulating plasma phospholipid

FA patterns were more strongly and significantly associated with

BMI, WC, WHtR and the MetS. The high-Satfat and

n-

3 VLC-PUFA

patterns were positively associated with adiposity and the MetS,

whereas the

n-

9 LC-MUFA and

n-

3 EFA patterns were inversely

associated with adiposity. These patterns may suggest possible

differences in FA metabolism between lean and overweight/obese

individuals. It should also be considered that, in a study population

with low-fat intakes, such as the PURE participants, plasma FA

levels may reflect endogenous FA generation rather than dietary

intakes, which could result in different findings than those reported

in other studies from affluent communities.

Our results are not sufficiently conclusive to make

recommendations on dietary FA intakes in this population. Further

prospective cohort studies that explain possible differences in

characteristics of FA metabolism among black South African men

and women are needed. More studies that apply the use of dietary

FA and plasma or tissue FA patterns are required to determine

whether the results from the current study can be generalised to

the black population of African descent.

References

1. Vorster HH, Kruger A, Margetts BM. The nutrition transition in Africa: can it be

steered into a more positive direction?

Nutrients

2011;

3

(4): 429–441.

2. Shisana O, Labadarios D, Rehle T, Simbayi L, Zuma K, Dhansay A,

et al

. The South

African National Health and Nutrition Examination Survey, 2012: SANHANES-1:

the health and nutritional status of the nation. Cape Town: HSRC Press, 2014.

Report No.: 0796924767.

3. National Department of Health. South Africa Demographic and Health Survey

2016: Key Indicators. Pretoria, South Africa and Rockville, Maryland, USA: NDoH,

Stats SA, South African Medical Research Council and ICF, 2017.

4. Kruger HS, Venter CS, Vorster HH. Obesity in African women in the North West

Province, South Africa is associated with an increased risk of no

n-

communicable

diseases: the THUSA study.

Br J Nutr

2001;

86

(06): 733–740.

5. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H,

et al

. A

comparative risk assessment of burden of disease and injury attributable to

67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic

analysis for the Global Burden of Disease Study 2010.

Lancet

2013;

380

(9859):

2224–2260.

6. Micha R, Khatibzadeh S, Shi P, Fahimi S, Lim S, Andrews KG,

et al

. Global,

regional, and national consumption levels of dietary fats and oils in 1990 and

2010: a systematic analysis including 266 country specific nutrition surveys.

Br

Med J

2014;

348

: 2272.

7. Bourne LT, Lambert EV, Steyn K. Where does the black population of South Africa

stand on the nutrition transition?

Public Health Nutr

2002;

5

(1A): 157–162.

8. Patterson EWR, Fitzgerald GF, Ross RP, Stanton C. Health implications of high

dietary omega-6 polyunsaturated fatty acids.

Nutr Metab Cardiovasc Dis

2012;

539426

: 1–6.

9. MacIntyre U, Kruger H, Venter C, Vorster H. Dietary intakes of an African

population in different stages of transition in the North West Province, South

Africa: the THUSA study.

Nutr Res

2002;

22

(3): 239–256.

10. Wentzel-Viljoen E, Lee S, Laubscher R, Vorster HH. Accelerated nutrition transition

in the North West Province of South Africa: results from the Prospective Urban

and Rural Epidemiology (PURE-NWP-SA) cohort study, 2005 to 2010.

Public

Health Nutr

2018;

21

: 1–12.

11. Smuts CM, Wolmarans P. The importance of the quality or type of fat in the diet:

a food-based dietary guideline for South Africa.

Sth Afr J Clin Nutr

2013;

26

(3):

S87–S99.

12. Dehghan MMA, Zhang X, Swaminathan S, Li W, Mohan V, Iqbal R,

et al

,

Prospective Urban Rural Epidemiology study investigators. Associations of fats

and carbohydrate intake with cardiovascular disease and mortality in 18 countries

from five continents (PURE): a prospective cohort study.

Lancet

2017;

390

(10107):

2050–2062.

13. Pickens CA, Sordillo LM, Comstock SS, Harris WS, Hortos K, Kovan B,

et al

.

Plasma phospholipids, no

n-

esterified plasma polyunsaturated fatty acids and

oxylipids are associated with BMI.

Prostaglandins, Leukotrienes Essential Fatty

Acids

2015;

95

: 31–40.

14. Fretts AMMD, Siscovick DS, King IB, McKnight B, Psaty BM, Rimm EB,

et al

.

Associations of plasma phospholipid SFAs with total and cause-specific mortality in

older adults differ according to SFA chain length.

J Nutr

2016;

146

(2): 298–305.

15. Yang WS, Chen PC, Hsu HC, Su TC, Lin HJ, Chen MF,

et al

. Differential effects of

saturated fatty acids on the risk of metabolic syndrome: a matched case-control

and meta-analysis study.

Metabolism

2018;

83

: 42–49.

16. Yamazaki Y, Kondo K, Maeba R, Nishimukai M, Nezu T, Hara H. The proportion

of nervonic acid in serum lipids is associated with serum plasmalogen levels and

metabolic syndrome.

J Oleo Sci

2014;

63

(5): 527–537.

17. Aglago EKBC, Torres-Mejía G, Angeles-Llerenas A, Gunter MJ, Romieu I, Chajès

V. Association between serum phospholipid fatty acids levels and adiposity in

Mexican women.

J Lipid Res

2017: P73643– P73677.

18. Mayneris-Perxachs J, Guerendiain M, Castellote AI, Estruch R, Covas MI, Fito M,

et al

. Plasma fatty acid composition, estimated desaturase activities, and their

relation with the metabolic syndrome in a population at high risk of cardiovascular

disease.

Clin Nutr

2013;

33

(1): 90–97.

19. Mozaffarian D, Cao H, King IB

et al

. Circulating palmitoleic acid and risk of

metabolic abnormalities and new-onset diabetes.

Am J Clin Nutr

2010;

92

(6):

1350–1358.

20. Micallef MMI, Phang M, Garg M. Plasma

n-

3 polyunsaturated fatty acids are

negatively associated with obesity.

Br J Nutr

2009;

102

(09): 1370–1374.

21. Huang T, Bhulaidok S, Cai Z, Xu T, Xu F, Wahlqvist ML,

et al

. Plasma phospholipids

n-

3 polyunsaturated fatty acid is associated with metabolic syndrome.

Mol Nutr

Food Res

2010;

54

(11): 1628–1635.

22. Li K, Brennan L, McNulty BA, Bloomfield JF, Duff DJ, Devlin NF,

et al

. Plasma fatty

acid patterns reflect dietary habits and metabolic health: A cross-sectional study.

Mol Nutr Food Res

2016;

60

(9): 2043–2052.

23. Kabagambe EK, Tsai MY, Hopkins PN, Ordovas JM, Peacock JM, Borecki IB,

et al

.

Erythrocyte fatty acid composition and the metabolic syndrome: a National Heart,

Lung, and Blood Institute GOLDN study.

Clin Chem

2008;

54

(1): 154–162.